IP Library Granted Patent US 7,906,487
Granted Patent B2
US 7,906,487 · App. 10/515,018 · Granted Mar 15, 2011

Method of utilizing physiological activity of rare saccharide and composition containing rare saccharide

Assignees: Fushimi Pharmaceutical Co., Ltd.; Teikoku Seiyaku Co., Ltd.; National University Corporation Kagawa University; Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,906,487
App. No.
10/515,018
Granted
Mar 15, 2011
Kind
B2
Abstract

A method of utilizing the physiological activity of a rare saccharide, wherein physiological-activity sensitive cells are treated with the rare saccharide to modify the function of the cells. A composition containing, as an active ingredient, a rare saccharide which is introduced into physiological-activity sensitive cells and has an effect of modifying the function of the cells. The cells are human cells. The composition is a functional food, a drug, or a cosmetic. The rare saccharide is a rare saccharide belonging to aldose and/or ketose. The aldose is D-allose, and the cells are selected from the group consisting of cancer-cell proliferation inhibitory activity sensitive cells and active-oxygen production inhibitory activity sensitive cells. The ketose is D-psicose, and the cells are selected from the group consisting of chemokine secretion inhibitory activity sensitive cells, microglia migration inhibitory activity sensitive cells, and hypoglycemic activity sensitive cells.

Claims (6)

1. A method of treating diabetes in a patient, comprising:

administering a composition having D-psicose as an active ingredient to said patient.

2. A method of treating arteriosclerosis in a patient, comprising:

administering a composition having D-psicose as an active ingredient to said patient.

3. A method of treating necrosis of hippocampus neurons caused by ischemia in a patient, comprising:

administering a composition having D-allose as an active ingredient to said patient.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2022
From: HAYASHIBARA CO., LTD.; FUSHIMI PHARMACEUTICAL CO., LTD.
To: MATSUTANI CHEMICAL INDUSTRY CO., LTD.
Reel/Frame 058638/0677 →
MERGER Recorded Aug 23, 2013
From: KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO
To: HAYASHIBARA CO., LTD.
Reel/Frame 031076/0442 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2008
From: FUSHIMI PHARMACEUTICAL CO., LTD.; TEIKOKU SEIYAKU CO., LTD.; NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY; KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO; SHIKOKU RESEARCH INSTITUTE INCORPORATED
To: FUSHIMI PHARMACEUTICAL CO., LTD.; TEIKOKU SEIYAKU CO., LTD.; NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY; KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO
Reel/Frame 020422/0914 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2006
From: IZUMORI, KEN; TOKUDA, MASAAKI; ITANO, TOSHIFUMI; MIYAMOTO, OSAMU; ISHIDA, TOSHIHIKO; MURAO, KOJI; MUNEUCHI, GAN; YAMAGUCHI, FUMINORI; TANAKA, TERUKAZU; UEKI, MASAAKI; HIROOKA, KAZUYUKI; TAMINATO, TOMOHIKO; TASAKA, TAIZO; HOSSAIN, MOHAMMAD AKRAM
To: NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY
Reel/Frame 017163/0570 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2005
From: TAKAHASHI, TAKEO
To: FUSHIMI PHARMACEUTICAL CO., LTD.
Reel/Frame 016706/0446 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2005
From: ISHIDA, YUTAKA
To: SHIKOKU RESEARCH INSTITUTE INCORPORATED
Reel/Frame 016706/0662 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2005
From: NAGATA, MITSUHIRO
To: TEIKOKU SEIYAKU CO., LTD.
Reel/Frame 016708/0641 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2005
From: TSUSAKI, KEIJI
To: KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO
Reel/Frame 016688/0042 →
Priority Claims (1)
JP 2002-148370 · May 22, 2002 · national
Continuity (1)
Related Publication 20050245459A1 · Nov 3, 2005